García-Escudero
García-Escudero has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo González-Cámpora
Department of Pathology, Virgen Macarena University Hospital and University of Seville Medical School, Seville, Spain
7 shared publications - Ana Vallejo-Benítez
Servicio de Anatomía Patológica, Hospital Universitario Virgen Macarena, Sevilla, España
2 shared publications Angel Caunedo-Álvarez
2 shared publications- Hugo Galera-Ruiz
Department of Otolaryngology, Head and Neck Surgery, University of Seville, Seville, Spain
2 shared publications Javier Brugal-Molina
2 shared publicationsManuel Rodríguez-Téllez
2 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 30, 8-11
Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature
- 1 October 2017
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 30, 8-11
Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature
- 1 October 2016
- Published by Elsevier in Revista Española de Patología
- Vol. 49 (4) , 234-238
Hiperplasia difusa idiopática de células neuroendocrinas de pulmón (DIPNECH): una entidad preneoplásica, infradiagnosticada y poco conocida
- 1 October 2016
- Published by Elsevier in Revista Española de Patología
- Vol. 49 (4) , 234-238
Hiperplasia difusa idiopática de células neuroendocrinas de pulmón (DIPNECH): una entidad preneoplásica, infradiagnosticada y poco conocida
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S851-S852
Tu1128 Stem Cells From Submucosal Glands as a Possible Origin for Barretts Esophagus Epithelium
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S851-S852
Tu1128 Stem Cells From Submucosal Glands as a Possible Origin for Barretts Esophagus Epithelium
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1012
Tu2058 Usefulness of Immunohistochemical Biomarkers CD133, Racemase and Twist for Progression in Barretts Esophagus and Esophageal Adenocarcinoma
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1012
Tu2058 Usefulness of Immunohistochemical Biomarkers CD133, Racemase and Twist for Progression in Barretts Esophagus and Esophageal Adenocarcinoma
- 1 November 2013
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 49 (11) , 494-496
Lipoma endobronquial: una causa poco frecuente de obstrucción bronquial
- 1 November 2013
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 49 (11) , 494-496
Lipoma endobronquial: una causa poco frecuente de obstrucción bronquial
- Open Access
- 30 October 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 150
Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
Gastrointestinal stromal tumours (GISTs) are the most common primary mesenchymal neoplasia in the gastrointestinal tract, although they represent only a small fraction of total gastrointestinal malignancies in adults (<2%). GISTs can be located at any level of the gastrointestinal tract; the stomach is the most common location (60-70%), in contrast to the rectum, which is most rare (4%). When a GIST invades into the adjacent prostate tissue, it can simulate prostate cancer. In this study, we report on a case comprising the unexpected collision between a rectal GIST tumour and a prostatic adenocarcinoma.
- 30 October 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 150
Open AccessCollision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
Gastrointestinal stromal tumours (GISTs) are the most common primary mesenchymal neoplasia in the gastrointestinal tract, although they represent only a small fraction of total gastrointestinal malignancies in adults (<2%). GISTs can be located at any level of the gastrointestinal tract; the stomach is the most common location (60-70%), in contrast to the rectum, which is most rare (4%). When a GIST invades into the adjacent prostate tissue, it can simulate prostate cancer. In this study, we report on a case comprising the unexpected collision between a rectal GIST tumour and a prostatic adenocarcinoma.
- 1 April 2008
- Vol. 30 (2)
W43X SDHD mutation in sporadic head and neck paraganglioma.
To analyze the presence of SDHD gene mutations in patients with sporadic head and neck paraganglioma.
- 1 April 2008
- Vol. 30 (2)
W43X SDHD mutation in sporadic head and neck paraganglioma.
To analyze the presence of SDHD gene mutations in patients with sporadic head and neck paraganglioma.
- 12 January 2007
- Vol. 26, 4937-42
Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
Liposarcoma is a heterogeneous group of soft tissue sarcomas in which definitive prognostic parameters need to be identified. The series included 33 consecutive soft tissue (well-differentiated, WDLPS, n=19; and dedifferentiated, DDLPS, n=14) liposarcoma. Clinicopathological variables included age, gender, body location, degree of dedifferentiation and mitotic count. The rrolecular analysis included MDM2, CDK4 and TP53 expressions and chromosome-12 copy number alterations. Centrally located (retroperitoneal, abdominal cavity or groin region) WDLPS had more dedifferentiation (p=0.001). Patients with DDLPS and a high mitotic rate died (p=0.070) or experienced recurrencies (p=0.029) more frequently. Co-expression of MDM2/CDK4 (p=0.001) and TP53 accumulation (p=0.017) related to dedifferentiation but not to recurrence or death, both in WDLPS and DDLPS. DDLPS had higher centromeric chromosome-12 copy number than WDLPS (p=0.013), but this was unrelated to recurrence or death. Central location is a risk factor in WDLP. Co-expression of MDM2/CDK4/TP53 and chromosome-12 alterations characterize DDLPS suggesting a link with dedifferentiation.
- 12 January 2007
- Vol. 26, 4937-42
Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
Liposarcoma is a heterogeneous group of soft tissue sarcomas in which definitive prognostic parameters need to be identified. The series included 33 consecutive soft tissue (well-differentiated, WDLPS, n=19; and dedifferentiated, DDLPS, n=14) liposarcoma. Clinicopathological variables included age, gender, body location, degree of dedifferentiation and mitotic count. The rrolecular analysis included MDM2, CDK4 and TP53 expressions and chromosome-12 copy number alterations. Centrally located (retroperitoneal, abdominal cavity or groin region) WDLPS had more dedifferentiation (p=0.001). Patients with DDLPS and a high mitotic rate died (p=0.070) or experienced recurrencies (p=0.029) more frequently. Co-expression of MDM2/CDK4 (p=0.001) and TP53 accumulation (p=0.017) related to dedifferentiation but not to recurrence or death, both in WDLPS and DDLPS. DDLPS had higher centromeric chromosome-12 copy number than WDLPS (p=0.013), but this was unrelated to recurrence or death. Central location is a risk factor in WDLP. Co-expression of MDM2/CDK4/TP53 and chromosome-12 alterations characterize DDLPS suggesting a link with dedifferentiation.